Healthcare - Biotechnology - NASDAQ - US
$ 9.17
-9.21 %
$ 525 M
Market Cap
-5.12
P/E
BALANCE SHEET
277 M
ASSETS
23 M
LIABILITIES
254 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Olema Pharmaceuticals, Inc.
| Current Assets | 267 M |
| Cash & Short-Term Investments | 262 M |
| Receivables | 673 K |
| Other Current Assets | 4.03 M |
| Non-Current Assets | 10.4 M |
| Long-Term Investments | 0 |
| PP&E | 3.26 M |
| Other Non-Current Assets | 7.17 M |
| Current Liabilities | 21.6 M |
| Accounts Payable | 2.7 M |
| Short-Term Debt | 1.98 M |
| Other Current Liabilities | 16.9 M |
| Non-Current Liabilities | 1.43 M |
| Long-Term Debt | 1.43 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 68.5 | 23.7 | 287.2 | 338.5 | 68 K | 3.1 |
| Short Term Investments | 193.3 | 180.7 | 273.4 | 0 | 0 | 0 |
| Receivables | 0.7 | 0.3 | 0 | 0 | 0 | 0 |
| Inventory | 0 | (0.3) | (0.4) | 0 | 0 | 0 |
| Other Current Assets | 4.0 | 4.2 | 3.3 | 3.6 | 35 K | 93 K |
| Total Current Assets | 266.5 | 208.9 | 287.2 | 342.1 | 0.1 | 3.2 |
| PP&E | 3.3 | 4.0 | 4.7 | 75 K | 26 K | 26 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 7.2 | 2.8 | 4.0 | 0.5 | 3 K | 3 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 276.9 | 215.6 | 295.9 | 342.7 | 0.1 | 3.3 |
| LIABILITIES | ||||||
| Accounts Payable | 2.7 | 0.4 | 23 K | 0.7 | 0.9 | 0.1 |
| Short Term Debt | 2.0 | 1.0 | 1.9 | 0 | 0 | 0 |
| Other Current Liabilities | 16.9 | 15.1 | 7.0 | 3.2 | 0.4 | 85 K |
| Total Current Liabilities | 21.6 | 16.5 | 9.0 | 4.6 | 1.4 | 0.2 |
| Long Term Debt | 1.4 | 1.6 | 2.4 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 9.3 |
| Total Liabilities | 23.1 | 18.1 | 11.4 | 4.6 | 10.7 | 9.5 |
| EQUITY | ||||||
| Common Stock | 4 K | 3 K | 3 K | 3 K | 1 K | 1 K |
| Retained Earnings | (305.6) | (209.0) | (104.2) | (33.1) | (10.8) | (6.4) |
| Other Accumulative Comprehensive Income/Loss | 0.3 | (1.8) | (0.1) | (342.7) | (9.3) | 71 K |
| Total Equity | 253.9 | 197.5 | 284.6 | 338.1 | (10.6) | (6.3) |
| Total Liabilities and Equity | 276.9 | 215.6 | 295.9 | 342.7 | 0.1 | 3.3 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 45.2 | 40.0 | 39.5 | 39.3 | 40.2 | 14.1 |